Site map

Pages

• Abdelhakim, Morocco
• About MS
  • MS in Children
  • Research Awards Contact Us
  • Treatments and therapies
    • Complementary therapies 
    • Disease-modifying therapies
    • Rehabilitation
      • Eloisa’s rehabilitation journey: An MS rehabilitation example
      • Finding and accessing rehabilitation services
    • Stem cell therapy
    • Treating MS symptoms
    • Treatment during a relapse
  • What is MS?
  • Causes of MS
  • Types of MS
  • Diagnosing MS
  • Symptoms
    • Bladder and bowel issues
    • Emotional and cognitive changes
    • Fatigue
    • Movement and coordination problems
    • Pain
    • Sexual problems
    • Vision issues
• About us
  • Annual accounts
  • Contact us
  • How we are funded
    • How we work with the healthcare industry
    • MSIF COVID-19 Response Initiative
    • Our income in 2019
    • Our income in 2020
    • Our income in 2022
    • Our income in 2024
    • Our income sources in 2016
    • Our income sources in 2017
    • Our income sources in 2018
    • Our income to date in 2021
  • How we are governed
    • Committees and expert groups
      • Board of trustees
    • International Medical and Scientific Board
  • Our members
  • Our staff
  • Our strategy
  • Who we are and what we do
    • Atlas of MS
      • Acknowledgements
      • Embed
      • Export
      • Raw
    • World MS Day
  • Conflict’s impact on people affected by MS
    • Information for People affected by MS impacted by the war in Ukraine
• Access to MS healthcare
  • Contact us for advice
  • Essential medicines for MS
    • Frequently asked questions: Essential medicines for MS
    • Public consultation now closed: Guidelines for essential disease-modifying therapies for multiple sclerosis for low-resource settings
  • Get the evidence
  • How to get started in advocacy
  • Improve access to MS treatment
  • Improve MS diagnosis
  • Learn from others
  • MSIF's work on access to MS healthcare
  • Off-label treatments for MS
  • People with MS share their challenges in accessing MS healthcare
  • Relevant publications
  • The WHO Intersectoral Global Action Plan for epilepsy and other neurological disorders
• Adriana, Argentina
• Answering today's big questions in progressive MS
• Complaints Policy and Procedure
• Cookie Policy
• Cycle For MS: Conquer the Tour
• Dealing with Safeguarding Concerns
• Disclaimer
• Donate
• Epstein-Barr virus and MS
• Essential medicines for MS
• Fundraise for MSIF
• Get involved
  • Join MSIF (MS organisations)
    • MSIF membership benefits
    • MSIF membership criteria
  • Our supporter promise
  • Sign up for our newsletters
    • Success
  • Take part in an event
  • Thank you
  • Vanessa's story
  • Your questions on Access
• Hafizuddin, Malaysia
• Home
• Imane, Morocco
• Improving access to MS treatment and healthcare
• Interactive Test
• International Progressive MS Alliance
  • Catch-up on the Progressive MS Alliance webcasts
• Interview, photography and filming consent form
• Join the discussion on symptom management & well-being in progressive MS
• Living with MS
  • Ageing and MS
  • Caregivers
  • Education and employment
  • Family life
  • Find MS support near you
  • Intimacy
  • Keeping healthy
  • MS and menopause
  • Relationships
  • Smoking and MS
  • Telling people you have MS
  • Wellness practices 
  • What influences quality of life with MS and how can we improve it?
    • Seven principles to improve quality of life
• London Marathon 2026 - Registration Form
• Manage Subscriptions
  • Success
• Member login
  • Reset password
• MEMP Conflict of interest information
• MOLT panel Conflict of interest information
• MSIF Essential Medicines Panel Evidence-to-Decision Framework
• MSIF Safeguarding Policy
• MSIF Social Media Policy
• MSIF Whistleblowing Policy and Procedure
• News & Events
  • News & events
• Norzey, Malaysia
• Oumaima, Morocco
• Page not found
• Patient Reported Outcomes for MS
• Privacy Policy
• Public consultation now closed: Guidelines for the use of off-label azathioprine and rituximab for the treatment of MS in low-resource settings
• Register interest for the MSIF research award grants
• Registration submitted
• Reporting unreliable resource
• Research
  • Awards, grants and fellowships
    • Charcot Award
      • Charcot Award winners
    • Du Pré Grants
      • Du Pré Grant recipients
    • Global MS research fellowships
    • McDonald Fellowships
      • McDonald Fellowship recipients
    • Young Investigator Award
  • Key topics in MS research
    • Clinical research and trials
    • MS registries: putting people with MS at the heart of research
    • Progressive MS webinar transcript
    • Quality of life research in MS
    • Stem cell therapy for MS
• Resources
  • Submit an information resource to the hub
• Respect in the Workplace
• Sanae, Morocco
• Shahdar, Malaysia
• Sharifah, Malaysia
• Sign up for news on Kiss Goodbye to MS
• Site map
• Tarrbinder, Malaysia
• Terms and Conditions
• Thank you
• Thank you for completing an MSIF Membership Application Form
• Thank you for registering
• Thank you for registering for the TCS London Marathon 2026
• Thank you for registering for the webcast
• Thank you for registering!
• Thank you for reporting unreliable resource
• Thank you for submitting the appointment form.
• Thank you for your vote
• Thank you!
• Thank you.
• The May 50K
• The WHO Essential Medicines List – a landmark decision to add MS medicines | Webinar
• Traffic light guidelines event for MS organisations
• unsubscibe
• ¡Gracias por inscribirte!
• شكرًا لك على التسجيل.